Our Services
Medical Information
Helpful Resources
Published on: 10/1/2026
Yes, in certain cases: Shingrix is approved and recommended for adults 19 and older who are or will be immunodeficient or immunosuppressed due to disease or therapy, such as cancer treatment, organ transplant, HIV, or long-term steroid and immune-suppressing medications. Healthy adults under 50 are generally not eligible under routine guidelines, and insurance coverage often follows those same age and risk rules, so cost and access can vary. Timing also matters, since the two-dose series may be spaced one to two months apart depending on your immune status, and some providers prefer to vaccinate before starting immunosuppressive therapy. There are several other factors to consider, including prior shingles episodes, pregnancy, and current illness. See below to understand the full details before deciding what applies to you.
If you are weighing early vaccination, it usually starts with understanding your own risk profile and whether symptoms like nerve pain, tingling, or a one-sided rash need attention right now. A fast, free, online symptom check can help you clarify what you are experiencing, flag whether urgent care is warranted, and give you clear questions to bring to a clinician so you do not lose time guessing.
Last reviewed for medical accuracy: 10/01/2026
Shingles (herpes zoster) is caused by the reactivation of the chickenpox virus (varicella-zoster). It can lead to a painful rash and complications such as postherpetic neuralgia (long-lasting nerve pain). Vaccination is the best way to reduce your risk. You may be wondering: Can you get the shingles vaccine before 50? Here’s what you need to know, based on credible sources like the Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA).
Adults aged 18–49 may qualify for Shingrix if they have:
Consider discussing early shingles vaccination if you are under 50 and you:
Your healthcare provider can:
Shingrix is a non-live, recombinant vaccine that has been studied extensively:
Overall, Shingrix’s benefits in preventing shingles and its complications far outweigh the temporary discomfort of side effects for most people.
If you have concerns about possible shingles symptoms—such as tingling, itching, or a blistering rash—you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. This tool can help you decide if you need to seek prompt medical care.
Always speak to a doctor if you experience:
Your healthcare provider can offer personalized advice and ensure you get the right care at the right time.
(References)
* Hügle B, Suchowerskyj P, Schuster V. [Varicella vaccination: who should be vaccinated these days?]. MMW Fortschr Med. 2005 Feb 24;147(8):31-2, 34-5. PMID: 18441563.
* Wielawski IM. Shingles and the vaccine to prevent it. Am J Nurs. 2009 Jun;109(6):63-5. doi: 10.1097/01.NAJ.0000352478.78617.e2. PMID: 19478611; PMCID: PMC2939832.
* Gelb LD. Reducing the incidence and severity of herpes zoster and PHN with zoster vaccination. J Am Osteopath Assoc. 2009 Jun;109(6 Suppl 2):S18-21. PMID: 19553631.
* Stier DM, Weber IB, Staples JE. Lack of interference by zoster vaccine with the immune response to yellow fever vaccine. J Travel Med. 2012 Mar-Apr;19(2):122-3. doi: 10.1111/j.1708-8305.2011.00585.x. Epub 2012 Feb 28. PMID: 22414038; PMCID: PMC4669900.
* Taking a shot at shingles. Johns Hopkins Med Lett Health After 50. 2012 Aug;24(7):8. PMID: 23033561.
* Cogman AR, Chakravarty EF. The case for Zostavax vaccination in systemic lupus erythematosus. Vaccine. 2013 Aug 12;31(36):3640-3. doi: 10.1016/j.vaccine.2013.05.085. Epub 2013 Jun 3. PMID: 23742992; PMCID: PMC3952213.
* Oxman MN, Schmader KE. Editorial commentary: zoster vaccine in immunocompromised patients: time to reconsider current recommendations. Clin Infect Dis. 2014 Oct;59(7):920-2. doi: 10.1093/cid/ciu501. Epub 2014 Aug 4. PMID: 25097080.
* Greenberg J. Ten Immunization-Related Tips in Outpatient Practice. Am J Med. 2017 Apr;130(4):417-419. doi: 10.1016/j.amjmed.2016.09.040. Epub 2016 Nov 4. PMID: 27818229.
* Xu F, deJong N, Kappelman MD, Greenlund KJ, Carlson SA. Primary Care Professionals' Attitudes Towards Vaccination Recommendation for Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2023 May 2;29(5):726-734. doi: 10.1093/ibd/izac129. PMID: 35779060.
* Stempniewicz N, Davenport E, Wang J, Sweeney C. Herpes zoster vaccination: Primary care provider knowledge, attitudes, and practices. Hum Vaccin Immunother. 2025 Dec;21(1):2488093. doi: 10.1080/21645515.2025.2488093. Epub 2025 Apr 18. PMID: 40249278; PMCID: PMC12013443.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.